The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Two-Year Outcome of Vagus Nerve Stimulation in Treatment-Resistant Depression
Open accessAbstract
One of the major goals of antidepressant treatment is a sustained response and remission of depressive symptoms. Some of the previous studies of vagus nerve stimulation (VNS) have suggested antidepressant effects. Our naturalistic study assessed the efficacy and the safety of VNS in 74 European patients with therapy-resistant major depressive disorder. Psychometric measures were obtained after 3, 12, and 24 months of VNS. Mixed-model repeated-measures analysis of variance revealed a significant reduction (P < or = 0.05) at all the 3 time points in the 28-item Hamilton Rating Scale for Depression (HRSD28) score, the primary outcome measure. After 2 years, 53.1% (26/49) of the patients fulfilled the response criteria (> or =50% reduction in the HRSD28 scores from baseline) and 38.9% (19/49) fulfilled the remission criteria (HRSD28 scores < or = 10). The proportion of patients who fulfilled the remission criteria remained constant as the duration of VNS treatment increased. Voice alteration, cough, and pain were the most frequently reported adverse effects. Two patients committed suicide during the study; no other deaths were reported. No statistically significant differences were seen in the number of concomitant antidepressant medications. The results of this 2-year open-label trial suggest a clinical response and a comparatively benign adverse effect profile among patients with treatment-resistant depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The generator delivers intermittent electrical impulses through the vagus nerve to the brain (74).”
From Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders (2018) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Sackeïm, H. A., Prudic, J., Devanand, D. P., Nobler, M. S., Lisanby, S. H., Peyser, S., Fitzsimons, L., Moody, B. J., & Clark, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.5.425 · Cited by 800
(2001) · PubMed · Cited by 780
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707 · cited 1×
“Given that remission status predicts better functioning and a more favorable prognosis for this group of patients, achievement of remission should be the goal for both treatment and clinical trials.(4) However, achieving sustained response and remission remains a major challenge in the long-term management of patients…”
Treatment non‐adherence in affective disorders
Lingam, R., & Scott, J. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.1r084.x · Cited by 635
Resistance to antidepressant medications and short-term clinical response to ECT
Prudic, J., Haskett, R. F., Mulsant, B. H., Malone, K. M., Pettinati, H. M., Stephens, S., Greenberg, R. M., Rifas, S., & Sackeïm, H. A. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.985 · Cited by 437
Rush, A. J., Sackeïm, H. A., Marangell, L. B., George, M. S., Brannan, S. K., Thomas, S., Lavori, P., Howland, R. H., Kling, M. A., Rittberg, B. R., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.024 · Cited by 407
Khan, A., Khan, S., Kolts, R. L., & Brown, W. A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.790 · Cited by 393
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
Nahas, Z., Marangell, L. B., Husain, M. M., Rush, A. J., Sackeim, H. A., Lisanby, S. H., Martinez, J. M., & George, M. S. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0902 · Cited by 390
Research works printed but not linked: 1
- Rush, 2005, Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial., Biol Psychiatry, 58, 347, 10.1016/j.biopsych.2005.05.025 · DOI · Paper page
Cited by
Sorted by citations
Items 101–178 of 178
Croft, J., LaMacchia, Z. M., Alderete, J. F., Maestas, A., Nguyen, K., & O’Hara, R. B. (2025) · Military Medicine · doi:10.1093/milmed/usaf063 · Cited by 11
Trapp, N. T., Xiong, W., & Conway, C. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_157 · Cited by 11
Kaczmarczyk, M., Antosik-Wójcińska, A. Z., Dominiak, M., & Święcicki, Ł. (2020) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/115191 · Cited by 10
“Generator impulsów jest programowany, by wysyłał impulsy elektryczne w regularnych odstępach czasu, przy czym parametry stymulacji są dostosowywane indywidualnie do pacjenta, stopniowo podwyższane do granicy akceptowanej „bez dolegliwości” [8].”
Salloum, N. C., Walker, M. C., Gangwani, S., & Conway, C. R. (2017) · Bipolar Disorders · doi:10.1111/bdi.12463 · Cited by 10
„Auch die Electricität leistet keine Wunder!“
Steinberg, H. (2012) · Der Nervenarzt · doi:10.1007/s00115-012-3644-0 · Cited by 10
Vagus Nerve Stimulation for the Treatment of Heart Failure
Asad, Z. U. A., & Stavrakis, S. (2019) · Bioelectronics in Medicine · doi:10.2217/bem-2019-0012 · Cited by 10
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Moeller, S., Lücke, C., Heinen, C., Bewernick, B. H., Aydın, M., Lam, A. P., Grömer, T. W., Philipsen, A., & Müller, H. (2019) · Journal of Visualized Experiments · doi:10.3791/58264 · Cited by 11
A narrative review on invasive brain stimulation for treatment-resistant depression
Dandekar, M. P., Díaz, A. P., Rahman, Z., da Silva, R. H., Nahas, Z. H., Aaronson, S. T., Selvaraj, S., Fenoy, A. J., Sanches, M., Soares, J. C., et al. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2021-1874 · Cited by 12
Pandurangi, A. K., Bledowski, C., & Bledowski, J. (2012) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2011.11.009 · Cited by 11
Łysik, A., Logoń, K., Szczygieł, A., Wołoszczak, J., Wrześniewska, M., & Leszek, J. (2025) · GeroScience · doi:10.1007/s11357-025-01615-8 · Cited by 11
“The device delivers continuous stimulation, with adjustable parameters such as current, pulse width, and frequency [74].”
Die Vagusnervstimulation bei konservativ therapierefraktärer Epilepsie und Depression
Möbius, H., & Welkoborsky, H. (2022) · Laryngo-Rhino-Otologie · doi:10.1055/a-1660-5591 · Cited by 9
“In 2010, the first transcutaneous vagus nerve stimulators (tVNS) were approved in Europe for application in the area of the auricle (auricular branch), first for therapy of epilepsy and depression [28], since 2012, it has also been approved for pain therapy [36].”
BackgroundYamamoto, M., Hirakata, H., & Toda, K. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1777975 · Cited by 11
“Early pilot studies reported reductions in depression scores following vagus nerve stimulation (Rush et al., 2000), and some long-term follow-up studies suggested sustained improvement over one to 2 years (Rush et al., 2000; Bajbouj et al., 2010).”
Zhang, W., Mou, Z., Zhong, Q., Liu, X., Lan, Y., Gou, L., Chen, Z., So, K., & Zhang, L. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1393549 · Cited by 8
“…in patients with treatment-resistant depression ranged from 42% to 53.1% ( ≥ 50% reduction in the Hamilton Depression Scale score from baseline) (26), and the mechanism is speculated to the modulation of cytokines and the regulation of microglial activation to attenuate the in fl ammatory…”
BackgroundInfluentialPeripheral Neuromodulation: An Update
Goroszeniuk, T., & Król, A. (2017) · Ból · doi:10.5604/01.3001.0010.0205 · Cited by 7
Novel treatments of depression: bridging the gap in current therapeutic approaches
Jagtiani, A. (2024) · Exploration of neuroscience · doi:10.37349/en.2024.00049 · Cited by 6
Asmar, K. E., Annan, N. B., Khoury, R., Colle, R., Martin, S., Ghoul, T. E., Trabado, S., Chanson, P., Fève, B., Verstuyft, C., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291722003919 · Cited by 8
“The attrition rate/drug discontinuation among the NRTT group is consistent with other prospective studies from the literature on treating depression (Bajbouj et al., 2010; Sirey et al., 2020).”
ResultNeurosurgical Breakthroughs of the Last 50 Years: A Historical Journey Through the Past and Present
Jesús, O. D. (2025) · World Neurosurgery · doi:10.1016/j.wneu.2025.123816 · Cited by 5
Makarov, S. N., Bogdanov, G. P., Noetscher, G. M., Appleyard, W., Ludwig, R., Joutsa, J., & Deng, Z. (2019) · Springer eBooks · doi:10.1007/978-3-030-21293-3_5 · Cited by 5
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Moeller, S., Lücke, C., Heinen, C., Bewernick, B. H., Aydın, M., Lam, A. P., Grömer, T. W., Philipsen, A., & Müller, H. (2019) · Journal of Visualized Experiments · doi:10.3791/58264-v · Cited by 5
Clinical Applications of Neuromodulation in Psychiatry
Shiozawa, P., Raza, R., Cordeiro, Q., & Brunoni, A. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1408-1_14 · Cited by 5
Yampolsky, C., & Bendersky, D. (2014) · Surgical Neurology International · doi:10.4103/2152-7806.137936 · Cited by 4
“Schlaepfer y col[137] (2008) y Bajbouj[11] (2010) 54/74 con depresión mayor 20/74 con trastorno bipolar VNS A los 3 meses, el 37% eran respondedores (reducción≥50% en la HAMD) y el 17% tenían remisión de la depresión (HAMD<10).”
BackgroundInfluentialVagus nerve stimulation for treatment‐refractory depression
Conway, C. R., Gott, B. M., & Azhar, N. (2015) · Wiley eBooks · doi:10.1002/9781118801086.ch18 · Cited by 4
Zhou, X., Chen, J., Colas, C., Hupin, D., & Killian, M. (2025) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2025-002677 · Cited by 3
Influence of Vagus Nerve Stimulation on Mood and Associated Disorders
Bottari, S. A., Rodriguez, A., & Williamson, J. B. (2023) · Neuromethods · doi:10.1007/978-1-0716-3465-3_7 · Cited by 4
Khan, A., Ahmed, R., Kotapati, V. P., Dar, S. K., Qamar, I., Jafri, A., Ibrahim, M., Kumar, P., & Begum, G. (2018) · International Journal of Medicine and Public Health · doi:10.5530/ijmedph.2018.3.26 · Cited by 3
Brain Stimulation in Psychiatry
Husain, M. M., Lisanby, S. H., & Kay, J. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch111 · Cited by 5
Neuropsychiatric Treatments for Epilepsy: Nonpharmacological Approaches
Lopez, M., & Kanner, A. M. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1742582 · Cited by 2
Review and Comparison of Somatic Therapies
Cusin, C., Soskin, D. P., & Dougherty, D. D. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.4.442 · Cited by 2
Complications of Cranial Nerve Stimulation
Pope, J. E. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2220-8.00003-9 · Cited by 2
VNS for the Treatment of Inflammatory Disorders of the Gastrointestinal Tract
Bonaz, B. L., Sinniger, V., Sonia Pellissier, A., & Clarençon, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-28612-9_9 · Cited by 3
Vagus Nerve Stimulation for Treatment-Resistant Depression: Current Status of This Novel Treatment
Conway, C. R., Hristidis, V. C., Gott, B. M., & Willie, J. T. (2022) · Psychiatric Annals · doi:10.3928/00485713-20220620-01 · Cited by 2
Davidson, B., Ibrahim, G. M., & Rutka, J. T. (2020) · Springer eBooks · doi:10.1007/978-3-319-72168-2_102 · Cited by 2
The Role of Nonpharmacological Interventions in Treatment‐resistant Depression
Schlaepfer, T. E., & Kayser, S. (2013) · Wiley eBooks · doi:10.1002/9781118556719.ch7 · Cited by 2
Self-citationComparative Side‐Effects of Neurosurgical Treatment of Treatment‐Resistant Depression
Keat, A. L. E., Li, K. T. J., Teo, C. H., & Soga, T. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70090 · Cited by 1
Managing the risk of suicide in people with treatment-resistant depression
Franz, P. J., & Alpert, J. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00039-6 · Cited by 1
Ribas, L. A. A., de Aguiar, P. H. P., Camargo, A. T. D. S., Ferreira, J. J. C., Lopes, V. H., Simis, A., Cottin, S. C., Gallani, N., & Simis, S. (2019) · Revista Chilena de Neurocirugía · doi:10.36593/rev.chil.neurocir.v44i1.48 · Cited by 1
Enhancing Heart Rate Variability
Utzinger-Wheeler, M. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00078-9 · Cited by 1
Ivanov, M. V., Stanovaya, V. V., Катышев, С. А., Yanushko, M. G., Второв, А. В., Клочков, М. Н., Ляскина, И. Ю., Нарышкин, А. Г., Galanin, I. V., Шаманина, М. В., et al. (2021) · Психиатрия психотерапия и клиническая психология · doi:10.34883/pi.2021.12.2.015 · Cited by 1
Hoffmann, C. M., Wang, J., Ali, R., & D'Souza, R. S. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.10967 · Cited by 1
“These regions are responsible for releasing neurotransmitters, including serotonin and norepinephrine, which have both anticonvulsive and antidepressant effects [45].”
Emerging Non-invasive Brain Stimulations for Schizophrenia
Wang, X., Blumberger, D. M., Ismail, P., & Foll, B. L. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837672059-00156 · Cited by 1
La stimulation du nerf vague (SNV)
Fovet, T., Bubrovszky, M., & Poulet, E. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0505-4_8 · Cited by 1
The Role of Stimulation Techniques
Schachter, S. C. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-22159-5_19 · Cited by 1
Enhancing Heart Rate Variability
Utzinger-Wheeler, M. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00096-7 · Cited by 1
A Review of the Potential Therapeutic Application of Vagus Nerve Stimulation During Childbirth
Enderli, T. (2017) · Cited by 1
When medication fails: Neurostimulation therapies for depression.
Carpenter, L. L., Megna, J. L., Herrera-Rojas, M., & Siddiqui, U. A. (2011) · Cited by 1
Vagal Nerve Stimulation in Treatment of Refractory Major Depression
Matthews, C., Tolomeo, S., & Matthews, K. (2013) · Wiley eBooks · doi:10.1002/9781118346396.ch15
Self-citationRedden, W. M., & Manepalli, J. N. (2015) · Current Geriatrics Reports · doi:10.1007/s13670-015-0151-8
Treatment-resistant depression and the elephant in the room
Jenkins, E. (2010) · Summit (Simon Fraser University)
Device-Based Treatment for PTSD
Lo, M.-C., Marin, M., Widge, A. S., & Milad, M. R. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780190457136.003.0025
Baumann‐Vogel, H., Sürücü, O., Baumann, C. R., & Böker, H. (2014) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2014.00290
Electroconvulsive Therapy and Neuromodulation Therapies
Christmas, D. M., & Matthews, K. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.018
Self-citationYu, Y., He, X., Wang, Y., Zhang, J., Tang, C., & Rong, P. (2020) · doi:10.21203/rs.3.rs-22344/v1
“Vagal nerve stimulation (VNS) was approved by the FDA for the treatment of chronic or recurring depression in 2005 [22].”
MethodNakai, Y., Nakai, F., Goda, C., Fushimi, M., & Miyake, M. (2021) · Journal of Japanese Society of Oral Oncology · doi:10.5843/jsot.33.137
Davidson, B., Ibrahim, G. M., & Rutka, J. T. (2019) · Springer eBooks · doi:10.1007/978-3-319-31512-6_102-1
Schläpfer, T. E., & Kayser, S. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_63
DEPINV：A WeChat Applet for Online Intervention of Depression Based on Accept Cognition TheoryPreprint
Xu, R., Zhang, Q., Zou, H., Tan, S., & Zhu, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1216471/v1
Steinke, K. V., Möbius, H., Christen, H. ‐., & Welkoborsky, H. (2022) · HNO · doi:10.1007/s00106-022-01164-y
Kumar, A., Pandey, A. K., & Okun, M. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00108-0
Optimizing Use of Vagus Nerve Stimulation for the Psychiatric Patient
Goldwaser, E. L., & Aaronson, S. T. (2022) · Psychiatric Annals · doi:10.3928/00485713-20220621-01
Merkl-Maßmann, A. (2022) · Elsevier eBooks · doi:10.1016/b978-3-437-23031-8.00027-3
Veiz, E. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10081 · Cited by 1
Yogarajah, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00113-3
Lymphocyte Antigen 6G Mediates Vagotomy‐Associated Reduction in Body Weight
Liu, T., Caravaca, A. S., Cai, M., Dai, W., Vacquié, J. J., Guo, Q., Holíček, P., Villet, M., Mendes, P. T., Zhang, Y., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202600151rr
“Although vagus nerve signaling is well-established in the regulation of short-term feeding behavior [37], and we observed transient reductions in food intake following vagotomy, the normalization of intake by day five suggests that the sustained weight loss may not be attributed solely to decreased…”
Álvarez‐Luquín, D. D., González-Fernández, R. R., Ichikawa-Escamilla, E., Torres-Velasco, M. E., Martínez-Martínez, E. J., Arce-Sillas, A., Juárez-Vaquera, V. H., Miranda-Narváez, C. L., Hernández, M., & Adalid-Peralta, L. V. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115764
Forbes, P., Brandt, E. S. L., Aichholzer, M., Uckermark, C., Bouzouina, A., Jacobsen, L., Repple, J., Kingslake, J., Reif-Leonhard, C., Reif, A., et al. (2026) · medRxiv · doi:10.64898/2026.04.16.26351003
Forbes, P., Brandt, E. S. L., Aichholzer, M., Uckermark, C., Bouzouina, A., Jacobsen, L., Repple, J., Kingslake, J., Reif-Leonhard, C., Reif, A., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122193
Vagus Nerve Modulation of the Gut–Brain Axis: Implications for Mental Health and Cognitive Function
Álvarez-Mejía, D., Mascialino, G., & León-Rojas, J. E. (2026) · The Neuroscientist · doi:10.1177/10738584261464980
Feffer, K., Strauss, I., Feldman, Z., Solomon, A., Bloemhof‐Bris, E., Nega, R., Gal, G., Hadar, A., & Domany, Y. (2026) · Journal of Ect · doi:10.1097/yct.0000000000001319
Hasanieh, K. A., Zorumski, C. F., Sackeim, H. A., Bunker, M. T., Aaronson, S. T., Rush, A. J., & Conway, C. R. (2026) · Current Addiction Reports · doi:10.1007/s40429-026-00797-1
“For the European trial [29 ]: only 49 of 74 patients remained evaluable at 24 months.”
Metadata
- Authors
- Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., Rau, H., Hoff, H.-J., Padberg, F., Müller-Siecheneder, F., Audenaert, K., van den Abbeele, D., Matthews, K., Christmas, D., Eljamel, S., & Heuser, I.
- Affiliations
- University Hospital of Umeå (SE)
- University of Dundee (GB)
- University Hospital Bonn (DE)
- National Hospital for Neurology and Neurosurgery (GB)
- University Hospital of Bern (CH)
- Ghent University Hospital (BE)
- Corresponding author
- Bajbouj, Malek
- Merkl, Angela
- Adolfsson, Rolf
- Heuser, Isabella
- ORCID
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2010-06
- Volume
- 30
- Issue
- 3
- Pages
- 273-281
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1987908185
- Cited by
- 178
- References
- 29
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 9 · 2023: 6 · 2022: 17 · 2021: 7 · 2020: 12 · 2019: 13 · 2018: 10 · 2017: 13 · 2016: 7 · 2015: 15 · 2014: 12 · 2013: 8 · 2012: 21
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- green
- biblio.ugent.be
- Licence
- other-oa
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- Topics
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- vagus nerve stimulation, treatment-resistant depression, major depressive disorder, long-term efficacy, remission, antidepressant response, adverse effects, voice change, suicide
- MeSH terms
- Adult, Aged, Depressive Disorder, Major, Major Depressive Disorder, Electric Stimulation Therapy, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Time Factors, Cohort Studies, Treatment Outcome, Vagus Nerve Stimulation, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
